Skip to main content
SpringerLink
Log in

UK recommendations for ongoing use of paclitaxel devices

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. comprising practising vascular surgeons and interventional radiologists, who were supported by the MHRA's toxicological and statistical experts.

  2. see Reactions 1753 p2; 803394218

Reference

  • Medicines and Healthcare products Regulatory Agency (UK). Recommendations for ongoing use of paclitaxel drug coated balloons (DCBs) and implantable drug eluting stents (DESs) in the treatment of patients with peripheral artery disease (PAD) (MDA/2019/023). Internet Document : [4 pages], 4 Jun 2019. Available from: URL: https://www.gov.uk/drug-device-alerts

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

UK recommendations for ongoing use of paclitaxel devices. Reactions Weekly 1757, 7 (2019). https://doi.org/10.1007/s40278-019-63235-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-63235-0

Search

Navigation